发明申请
US20120149746A1 ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING RETINAL DISEASES
有权
[3-(1-(1H-咪唑-4-基)乙基)-2-甲基苯基]甲醇用于治疗复发性疾病的ESTER PRO药物
- 专利标题: ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING RETINAL DISEASES
- 专利标题(中): [3-(1-(1H-咪唑-4-基)乙基)-2-甲基苯基]甲醇用于治疗复发性疾病的ESTER PRO药物
-
申请号: US13233382申请日: 2011-09-15
-
公开(公告)号: US20120149746A1公开(公告)日: 2012-06-14
- 发明人: Mohammed I. Dibas , Daniel W. Gil , Ken Chow , Liming Wang , Michael E. Garst , John E. Donello
- 申请人: Mohammed I. Dibas , Daniel W. Gil , Ken Chow , Liming Wang , Michael E. Garst , John E. Donello
- 申请人地址: US CA Irvine
- 专利权人: ALLERGAN, INC.
- 当前专利权人: ALLERGAN, INC.
- 当前专利权人地址: US CA Irvine
- 主分类号: A61K31/4174
- IPC分类号: A61K31/4174 ; A61P27/02 ; A61P27/06 ; C07D233/64
摘要:
The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
公开/授权文献
信息查询
IPC分类: